1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > OTC Analysis & Statistics, November 2016 (p8)

OTC Analysis & Statistics, November 2016 (p8)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

All regions

211-240 of about 4700 reports

Purchase Reports From Reputable Market Research Publishers

Ulcers Global Clinical Trials Review, H2, 2016

Ulcers Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by Global Data

Ulcers Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Ulcers Global Clinical Trials Review, H2, 2016" provides an overview of Ulcers clinical trials scenario. This ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Pathology, Therapy
  • Countries : World
Candidiasis Global Clinical Trials Review, H2, 2016

Candidiasis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by Global Data

Candidiasis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Candidiasis Global Clinical Trials Review, H2, 2016" provides an overview of Candidiasis clinical trials ...

  • Industries : Pathology, Pharmaceutical, Drug Discovery and Development, Therapy, Healthcare
  • Countries : World
Zollinger-Ellison Syndrome (Gastrinoma) Global Clinical Trials Review, H2, 2016

Zollinger-Ellison Syndrome (Gastrinoma) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by Global Data

Zollinger-Ellison Syndrome (Gastrinoma) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Zollinger-Ellison Syndrome (Gastrinoma) Global Clinical Trials Review, H2, ...

  • Industries : Pathology, Pharmaceutical, Therapy
  • Countries : World
Gastric Ulcers Global Clinical Trials Review, H2, 2016

Gastric Ulcers Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by Global Data

Gastric Ulcers Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Gastric Ulcers Global Clinical Trials Review, H2, 2016" provides an overview of Gastric Ulcers clinical ...

  • Industries : Pathology, Pharmaceutical, Drug Discovery and Development, Therapy, Healthcare
  • Countries : World
Infectious Diarrhea Global Clinical Trials Review, H2, 2016

Infectious Diarrhea Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by Global Data

Infectious Diarrhea Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Infectious Diarrhea Global Clinical Trials Review, H2, 2016" provides an overview of Infectious ...

  • Industries : Pathology, OTC, Pharmaceutical, Healthcare
  • Countries : World
Pain Relieving Drugs Market Forecast 2017-2027

Pain Relieving Drugs Market Forecast 2017-2027

  • $ 2508
  • Industry report
  • December 2016
  • by Visiongain

Report Details The global pain relieving drugs market is expected to grow at a CAGR of 2.1% from 2021-2027. The market is expected to grow from $67.8bn in 2016 to $75.2bn in 2027. How this report will ...

  • Industries : OTC
  • Countries : World
Consumer Health in Cameroon

Consumer Health in Cameroon

  • $ 2423
  • Industry report
  • January 2017
  • by Euromonitor International

As economic growth continued to be positive in 2016, GDP growth improved and so did the overall consumer health market. The stability of unit prices in chemists/pharmacies also encouraged increased expenditure ...

  • Industries : OTC
  • Countries : Cameroon
Consumer Health in Saudi Arabia

Consumer Health in Saudi Arabia

  • $ 2423
  • Industry report
  • December 2016
  • by Euromonitor International

The strong performance of consumer health over the review period was maintained in 2016, despite decreasing consumer spending due to the overall economic slowdown in Saudi Arabia, which was brought about ...

  • Industries : OTC
  • Countries : Saudi Arabia
Consumer Health in Singapore

Consumer Health in Singapore

  • $ 2423
  • Industry report
  • December 2016
  • by Euromonitor International

Consumer health in Singapore continued to post solid retail current value growth in 2016. This can be attributed to stronger consumer health awareness as a result of increasing media coverage of health ...

  • Industries : OTC
  • Countries : Singapore
Consumer Health in the United Arab Emirates

Consumer Health in the United Arab Emirates

  • $ 2423
  • Industry report
  • December 2016
  • by Euromonitor International

Consumer health in the United Arab Emirates recorded stable current value growth in 2016, as the Ministry of Health continued to regulate the market by keeping prices low in the fast growing healthcare ...

  • Industries : OTC
  • Countries : United Arab Emirates
Consumer Health in South Africa

Consumer Health in South Africa

  • $ 2423
  • Industry report
  • December 2016
  • by Euromonitor International

Consumer health saw its strongest annual current value growth of the review period in 2016 thanks to a growing self-medication trend. This was partly due to long waiting times in the public healthcare ...

  • Industries : OTC
  • Countries : South Africa
Consumer Health in Estonia

Consumer Health in Estonia

  • $ 2423
  • Industry report
  • November 2016
  • by Euromonitor International

2016 results confirm that Estonia has fully recovered from recession. Over the counter medicine and food supplements have stabilised, and seen moderate value growth. Sports nutrition sales were boosted ...

  • Industries : OTC
  • Countries : Estonia
Dysmenorrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Dysmenorrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Dysmenorrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline ...

  • Industries : Hosting, Hosting
  • Countries : United States
Smoking Cessation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Smoking Cessation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Smoking Cessation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III ...

  • Industries : OTC, Hosting, Hosting, Pharmaceutical
  • Countries : United States
Tinea Cruris (Jock Itch)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Tinea Cruris (Jock Itch)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Tinea Cruris (Jock Itch)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

  • Industries : Pathology, OTC
  • Countries : United States
Constipation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Constipation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Constipation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline ...

  • Industries : Hosting, Hosting, Pathology
  • Countries : United States
Irritable Bowel Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Irritable Bowel Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Irritable Bowel Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

  • Industries : Pathology, Hosting, Hosting, OTC
  • Countries : United States
Hormone Replacement Therapy (HRT)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Hormone Replacement Therapy (HRT)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Hormone Replacement Therapy (HRT)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug ...

  • Industries : OTC
  • Countries : United States
Urinary Incontinence-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Urinary Incontinence-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Urinary Incontinence-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

  • Industries : Hosting, Hosting, OTC
  • Countries : United States
Primary Dysmenorrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Primary Dysmenorrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Primary Dysmenorrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

  • Industries : Hosting, Hosting, OTC
  • Countries : United States
Acid Indigestion / Heartburn/ Pyrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Acid Indigestion / Heartburn/ Pyrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Acid Indigestion / Heartburn/ Pyrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug ...

  • Industries : OTC
  • Countries : United States
Reflux Esophagitis (Gastroesophageal Reflux Disease)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Reflux Esophagitis (Gastroesophageal Reflux Disease)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Reflux Esophagitis (Gastroesophageal Reflux Disease)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed ...

  • Industries : Hosting, Hosting, Pathology, OTC
  • Countries : United States
Athlete%s Foot (Tinea Pedis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Athlete%s Foot (Tinea Pedis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Athlete's Foot (Tinea Pedis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

  • Industries : OTC
  • Countries : United States
Chronic Urticaria Or Hives-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Chronic Urticaria Or Hives-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Chronic Urticaria Or Hives-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

  • Industries : Hosting, Hosting, Pathology, OTC
  • Countries : United States
Migraine-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Migraine-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Migraine-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline ...

  • Industries : Hosting, Hosting
  • Countries : United States
Overactive Bladder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Overactive Bladder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Overactive Bladder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III ...

  • Industries : Hosting, Hosting, OTC
  • Countries : United States
Perennial Allergic Rhinitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Perennial Allergic Rhinitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Perennial Allergic Rhinitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

  • Industries : Hosting, Hosting, OTC, Chronic Disease
  • Countries : United States
Androgenic Alopecia - Pipeline Review, H2 2016

Androgenic Alopecia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • December 2016
  • by Global Markets Direct

Androgenic Alopecia - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Androgenic Alopecia – Pipeline Review, H2 2016, provides an ...

  • Industries : OTC, Pharmaceutical
  • Countries : Japan
Opioid-Induced Bowel Dysfunction (OBD or OIBD) - Pipeline Review, H2 2016

Opioid-Induced Bowel Dysfunction (OBD or OIBD) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • December 2016
  • by Global Markets Direct

Opioid-Induced Bowel Dysfunction (OBD or OIBD) - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Opioid-Induced Bowel Dysfunction ...

  • Industries : Therapy, Pharmaceutical
  • Countries : World
Tinea pedis (Athlete Foot) - Pipeline Review, H2 2016

Tinea pedis (Athlete Foot) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • December 2016
  • by Global Markets Direct

Tinea pedis (Athlete Foot) - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Tinea pedis (Athlete Foot) – Pipeline Review, H2 2016, ...

  • Industries : Pathology, OTC, Pharmaceutical
  • Countries : United States
About 6800 reports

Download Unlimited Documents from Trusted Public Sources

OTC Industry in Japan

  • February 2017
    8 pages
  • Vitamin  

  • Japan  

View report >

Otc Industry In Spain

February 2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.